Smoking in pregnancy: a risk factor for adverse neurodevelopmental outcome in preterm infants?

U Kiechl-Kohlendorfer1, E Ralser, U Pupp Peglow

  • 1Department of Paediatrics, Division of Neonatology, Neuropaediatrics and Metabolic Disorders, Innsbruck Medical University, Innsbruck, Austria. ursula.kohlendorfer@i-med.ac.at

Insights

Smoking during pregnancy is linked to poorer neurodevelopmental outcomes in preterm infants born before 32 weeks gestation. Reducing smoking in pregnancy is crucial for improving infant development.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Public Health

Background:

  • Preterm infants born before 32 weeks gestation are at high risk for neurodevelopmental delays.
  • Maternal smoking during pregnancy is a known risk factor for adverse pregnancy outcomes.

Purpose of the Study:

  • To investigate the association between smoking in pregnancy and neurodevelopmental outcomes at 2 years of age in preterm infants.
  • To identify risk factors for delayed development in this vulnerable population.

Main Methods:

  • Prospective enrollment of 181 preterm infants (gestational age <32 weeks).
  • Follow-up assessment at 2 years using Bayley Scales of Infant Development II.
  • Logistic regression analysis to identify risk factors for delayed motor or mental development (developmental index <85).

Main Results:

  • Smoking in pregnancy, low gestational age, low birth weight, small for gestational age, chronic lung disease, intracerebral hemorrhage, periventricular leucomalacia, and retinopathy of prematurity were associated with increased risk of delayed development.
  • Smoking in pregnancy, small for gestational age, and chronic lung disease remained significant predictors in multivariable analysis.

Conclusions:

  • Smoking during pregnancy is a significant predictor of adverse neurodevelopmental outcomes in preterm infants.
  • Strategies to reduce smoking in pregnancy should be strongly promoted to improve infant neurodevelopmental trajectories.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...